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A 43-year-old woman presented with a right breast lump that had enlarged over 5 months. She had chemoradiotherapy for non-
Hodgkin’s lymphoma in 1989. Histology revealed a malignant phyllodes tumour (PT) with liposarcomatous diﬀerentiation and
ductal carcinoma in situ (DCIS) within the tumour with invasive tubular carcinoma, DCIS, and lobular carcinoma in situ in
the surrounding breast. She had surgery and adjuvant radiotherapy. One year follow-up showed no recurrence or metastatic
disease. Liposarcomatous diﬀerentiation is uncommon in PTs, and coexisting carcinoma is rare with 38 cases in 31 reports in
the literature. Carcinoma is reported in malignant (n = 19), benign (n = 16) and in borderline PTs (n = 3) with invasive
carcinoma (n = 18) and pure in situ carcinoma (n = 19) recorded in equal frequency. Carcinoma is more commonly found within
the conﬁnes of benign PTs; whereas it is more often found surrounding the PT or in the contralateral breast in malignant PTs.
Previous radiotherapy treatment is reported in only two cases. The aetiology of co-existing carcinoma is unclear but the rarity of
previous radiotherapy treatment suggests that it is incidental. This case highlights the diverse pathology that can occur with PTs,
which should be considered when evaluating pathology specimens as they may impact on patient management.
1.Introduction
Phyllodestumors(PTs)ofthebreastareuncommonbiphasic
ﬁbroepithelial neoplasms that account for <1% of all breast
tumours. Most PTs are benign and carry a risk of local
recurrence whereas malignant PTs have a 13% risk of
haematogenous metastasis [1]. The distinction between
benign, borderline and malignant PT is based on the
assessment of a number of histological features including
inﬁltrative margin, stromal overgrowth, stromal atypia,
cellularity, and mitotic activity. However, while histological
features are helpful, they are not accurate predictors of
tumour behavior, and no single parameter is reliable in all
cases [2].
PTs are believed to arise from intralobular or periductal
stroma and may arise de novo or from pre-existing ﬁbroade-
nomas [2]. Up to 30% of PTs show malignant transforma-
tion, most often in the form of malignant transformation
of the stroma, which usually shows ﬁbrosarcomatous dif-
ferentiation and rarely heterologous sarcomatous elements.
Malignant transformation of epithelial elements is very rare
with only 38 cases reported in the literature. We present a
case of a malignant PT that contained heterologous liposar-
comatous stromal diﬀerentiation and exhibited a range of
epithelial pathology. Ductal carcinoma in situ (DCIS) was
presentwithinthePT;DCIS,invasivetubularcarcinoma,and
multiple foci of lobular carcinoma in situ (LCIS) were noted
intheadjacentbreasttissue.Althoughitisgenerallyaccepted2 Pathology Research International
Figure 1: Mammogram of the left breast. A relatively well-
circumscribedmasswaspresentinlowercentralaspectofthebreast.
that the prognosis of a patient with a malignant PT depends
on the nature of the PT, malignant epithelial components
should, if present, be taken into account when managing the
patient.
2.CaseReport
A 43-year-old woman presented with a palpable lump in the
central aspect of the left breast below the nipple. The lump
was present for ﬁve months. It had increased in size over
that time and was tender. Mammography showed a relatively
well-circumscribed 3.4cm mass in the lower central aspect
of the breast (Figure 1). An ultrasound-guided biopsy was
performedandshowedaﬁbroepitheliallesionwithincreased
stromal cellularity and nuclear atypia, consistent with a
PT. The patient had a history of non-Hodgkin’s lymphoma
involving the lumbar spine in 1989, which was treated with
chemotherapy and radiotherapy to the lumbar area.
A wide local excision of the left breast was performed
which was followed by a wider cavity excision and latissimus
dorsi ﬂap reconstruction. The patient was given adjuvant
radiotherapy. The breast received 50.4Gy at 1.8Gy per
fraction with a cone-down boost to the tumour bed, giving a
total dose of 63Gy to the area considered at the greatest risk
of recurrence. Follow-up after one year showed no evidence
of recurrence or metastasis. Axillary sampling was not
performed but no axillary lymphadenopathy was identiﬁed
at one year follow-up.
3.Pathological Findings
The wide local excision of the left breast, 75×60×30mm,
contained a well-deﬁned, partly encapsulated tumor,
25×35×27mm, with a papillary texture. A PT was
conﬁrmed histologically. The tumour showed the character-
istic enhanced intracanalicular growth pattern with leaf-like
projections into dilated cysts, extensive stromal overgrowth,
and marked stromal hypercellularity (Figure 2(a)). Frankly
malignant stromal features including nuclear pleomorphism
and a high mitotic count (19 per 10 high power ﬁelds)
were seen (Figure 2(b)). In many areas, liposarcomatous
diﬀerentiation, characterized by pleomorphic lipoblasts,
was present (Figure 2(c)). The margins of the PT were
focally inﬁltrative. The epithelial component within the
P Te x h i b i t e dh y p e r p l a s i ao fu s u a lt y p ea sw e l la sf o c io f
DCIS, intermediate grade, with cribriform and solid growth
patterns, without necrosis (Figure 2(d)). A small invasive
carcinoma, 2mm in size, was present at the periphery of the
PT close to the deep margin of the specimen (Figure 3(a)).
This was composed of well-formed tubules that lacked a
myoepithelial layer (Smooth Muscle Heavy Chain Myosin
and p63 negative) and was regarded as a grade 1 tumour
[3] although it was too small to grade accurately based on
the absence of suﬃcient high power ﬁelds for scoring of
mitotic activity. Oestrogen receptor was strongly expressed
and Her-2 was negative. The invasive tumour was adjacent
to a small duct with morphological features of low-grade
DCIS but there was no morphological transition between
invasive carcinoma and thestromalor epithelial components
of the adjacent PT. Multiple scattered foci of LCIS were also
present peripheral to the PT, conﬁrmed by downregulation
ofE-Cadherinstaining(Figures3(b)and3(c)).Thescattered
nature of the LCIS precludes accurate measurement of its
size.
The cavity re-excision specimen (190g, 98×97×
47mm) included skeletal muscle and showed no residual PT.
A single focus of DCIS, high-nuclear grade with comedo-
necrosis and microcalciﬁcation, 3mm in size, was present
within 1mm to the medial margin (Figure 3(d)). Multiple
foci of LCIS were also noted.
4. Discussion andReview
Metaplastic change within PTs is uncommon. In the largest
seriesofPTsreported,stromalmetaplasiawaspresentinonly
11 of 335 cases, and malignant transformation of epithelium
in the form of DCIS and LCIS was seen in only two cases
[17]. Stromal changes included adipose and chondromyxoid
elements and were seen in benign and borderline PTs
whereas malignant heterologous elements were reported
in malignant PTs. The latter was most commonly in the
form of liposarcomatous diﬀerentiation [17, 20, 24, 30, 33,
34], which does not equate with more aggressive clinical
behavior [30, 35]. Other forms of heterologous change are
reported in PTs including osteosarcoma, rhabdomyosarco-
mas, leiomyosarcoma, rhabdomyosarcoma, and angiosar-
coma [17, 36]. Epithelial change in the form of usual-type
epithelial hyperplasia is well recognized in PTs [17]b u t
epithelial metaplasia is uncommon. Apocrine and squamous
changes can occur but malignant epithelial transformation,
as reported in the present case, is exceptionally rare. This
case adds to the literature of 38 cases in 31 reports [1, 4–
33] of carcinoma arising either within and/or in association
with PT (Table 1). It demonstrates the range of changesPathology Research International 3
T
a
b
l
e
1
:
S
u
m
m
a
r
y
o
f
c
a
s
e
s
o
f
p
h
y
l
l
o
d
e
s
t
u
m
o
u
r
s
a
s
s
o
c
i
a
t
e
d
w
i
t
h
c
a
r
c
i
n
o
m
a
.
R
e
p
o
r
t
A
g
e
P
T
t
y
p
e
S
i
z
e
(
m
m
)
A
s
s
o
c
i
a
t
e
d
c
a
r
c
i
n
o
m
a
L
o
c
a
t
i
o
n
o
f
c
a
r
c
i
n
o
m
a
r
e
l
a
t
i
v
e
t
o
P
T
C
o
m
m
e
n
t
O
u
t
c
o
m
e
I
n
v
a
s
i
v
e
I
n
s
i
t
u
Y
a
m
a
g
u
c
h
i
e
t
a
l
.
[
4
]
5
4
B
P
T
1
5
0
D
C
I
S
W
i
t
h
i
n
A
W
a
t
1
1
m
o
n
t
h
s
R
a
m
d
a
s
s
a
n
d
D
i
n
d
y
a
l
[
5
]
6
9
B
P
T
N
S
I
D
C
W
i
t
h
i
n
C
o
m
p
l
e
x
c
a
r
c
i
n
o
m
a
w
i
t
h
c
l
e
a
r
c
e
l
l
,
s
e
c
r
e
t
o
r
y
a
n
d
s
q
u
a
m
o
u
s
d
i
ﬀ
e
r
e
n
t
i
a
t
i
o
n
N
A
P
a
r
ﬁ
t
t
e
t
a
l
.
[
1
]
2
6
B
P
T
3
3
I
D
C
D
C
I
S
W
i
t
h
i
n
M
e
t
a
s
t
a
t
i
c
a
d
e
n
o
c
a
r
c
i
n
o
m
a
i
n
4
o
f
1
3
L
N
A
W
a
t
3
6
m
o
n
t
h
s
K
o
d
a
m
a
e
t
a
l
.
[
6
]
4
7
B
P
T
1
7
0
I
L
C
D
C
I
S
W
i
t
h
i
n
L
u
m
p
p
r
e
s
e
n
t
f
o
r
1
2
y
e
a
r
s
b
e
f
o
r
e
t
r
e
a
t
m
e
n
t
A
W
a
t
1
0
8
m
o
n
t
h
s
D
e
R
o
s
a
e
t
a
l
.
[
7
]
7
7
B
P
T
∗
5
0
I
D
C
D
C
I
S
I
p
s
i
l
a
t
e
r
a
l
M
i
l
d
a
t
y
p
i
a
i
n
s
t
r
o
m
a
w
i
t
h
o
c
c
a
s
i
o
n
a
l
m
i
t
o
s
e
s
A
W
a
t
1
0
m
o
n
t
h
s
Y
a
s
u
m
u
r
a
e
t
a
l
.
[
8
]
4
7
B
P
T
1
3
0
I
D
C
W
i
t
h
i
n
A
W
a
t
6
6
m
o
n
t
h
s
K
n
u
d
s
e
n
a
n
d
O
s
t
e
r
g
a
a
r
d
[
9
]
7
1
B
P
T
7
0
D
C
I
S
,
L
C
I
S
W
i
t
h
i
n
N
A
G
r
o
v
e
a
n
d
D
e
i
b
j
e
r
g
K
r
i
s
t
e
n
s
e
n
[
1
0
]
7
1
B
P
T
1
9
0
D
C
I
S
W
i
t
h
i
n
H
i
s
t
o
r
y
o
f
i
r
r
a
d
i
a
t
i
o
n
t
o
o
v
a
r
i
e
s
f
o
r
c
l
i
m
a
c
t
e
r
i
c
m
e
n
s
t
r
u
a
l
d
i
s
o
r
d
e
r
s
A
W
a
t
4
m
o
n
t
h
s
C
h
r
i
s
t
e
n
s
e
n
e
t
a
l
.
[
1
1
]
4
2
–
5
8
B
P
T
1
0
–
2
0
I
D
C
I
p
s
i
l
a
t
e
r
a
l
I
D
C
i
n
c
l
o
s
e
r
e
l
a
t
i
o
n
t
o
a
r
e
c
u
r
r
e
n
t
P
T
R
I
P
a
f
t
e
r
3
m
o
n
t
h
s
f
r
o
m
m
e
t
a
s
t
a
t
i
c
c
a
r
c
i
n
o
m
a
I
s
h
i
d
a
e
t
a
l
.
[
1
2
]
B
P
T
5
6
P
a
p
i
l
l
o
t
u
b
u
l
a
r
W
i
t
h
i
n
A
W
a
t
3
0
m
o
n
t
h
s
S
t
o
n
e
-
T
o
l
i
n
e
t
a
l
.
[
1
3
]
5
9
B
P
T
/
N
S
2
2
0
I
D
C
C
o
n
t
r
a
l
a
t
e
r
a
l
R
e
c
u
r
r
i
n
g
P
T
a
n
d
F
A
o
v
e
r
3
6
-
y
e
a
r
p
e
r
i
o
d
A
W
a
t
1
5
m
o
n
t
h
s
L
e
o
n
g
a
n
d
M
e
r
e
d
i
t
h
[
1
4
]
4
7
B
P
T
4
0
I
T
C
W
i
t
h
i
n
T
h
r
e
e
r
e
c
u
r
r
e
n
c
e
s
o
f
B
P
T
.
L
C
I
S
i
n
s
e
c
o
n
d
r
e
c
u
r
r
e
n
c
e
a
n
d
I
T
C
i
n
t
h
i
r
d
r
e
c
u
r
r
e
n
c
e
A
W
a
t
2
1
m
o
n
t
h
s
R
i
c
h
a
r
d
s
a
n
d
W
A
Y
[
1
5
]
3
7
B
P
T
7
0
I
D
C
∗
∗
I
p
s
i
l
a
t
e
r
a
l
S
e
p
a
r
a
t
e
t
u
m
o
u
r
n
o
d
u
l
e
s
.
M
e
t
a
s
t
a
t
i
c
c
a
r
c
i
n
o
m
a
i
n
L
N
R
I
P
a
f
t
e
r
9
m
o
n
t
h
s
f
r
o
m
m
e
t
a
s
t
a
s
e
s
†
L
e
s
t
e
r
a
n
d
S
t
o
u
t
,
[
1
6
]
4
0
B
P
T
1
4
N
S
N
S
I
p
s
i
l
a
t
e
r
a
l
P
T
f
o
u
n
d
i
n
m
a
s
t
e
c
t
o
m
y
s
p
e
c
i
m
e
n
p
e
r
f
o
r
m
e
d
f
o
r
c
a
r
c
i
n
o
m
a
A
W
a
t
1
4
4
m
o
n
t
h
s
T
a
n
e
t
a
l
.
[
1
7
]
N
A
N
S
∞
N
A
D
C
I
S
I
p
s
i
l
a
t
e
r
a
l
N
A
T
a
n
e
t
a
l
.
[
1
7
]
N
A
N
S
∞
N
A
L
C
I
S
W
i
t
h
i
n
N
A
D
e
o
d
h
a
r
e
t
a
l
.
[
1
8
]
5
1
B
L
P
T
1
4
0
D
C
I
S
W
i
t
h
i
n
,
I
p
s
i
l
a
t
e
r
a
l
N
A
C
h
r
i
s
t
e
n
s
e
n
e
t
a
l
.
[
1
1
]
4
2
–
5
8
B
L
P
T
N
S
D
C
I
S
W
i
t
h
i
n
,
I
p
s
i
l
a
t
e
r
a
l
R
I
P
a
f
t
e
r
3
6
m
o
n
t
h
s
f
r
o
m
u
n
r
e
l
a
t
e
d
c
a
u
s
e
C
h
r
i
s
t
e
n
s
e
n
e
t
a
l
.
[
1
1
]
4
2
–
5
8
B
L
P
T
N
S
D
C
I
S
I
p
s
i
l
a
t
e
r
a
l
R
e
c
u
r
r
e
n
t
P
T
a
s
s
o
c
i
a
t
e
d
w
i
t
h
D
C
I
S
i
n
a
d
j
a
c
e
n
t
b
r
e
a
s
t
w
i
t
h
i
n
1
2
m
o
n
t
h
s
o
f
i
n
i
t
i
a
l
d
i
a
g
n
o
s
i
s
R
I
P
a
f
t
e
r
1
2
m
o
n
t
h
s
f
r
o
m
m
e
t
a
s
t
a
t
i
c
P
T
K
o
r
u
l
a
e
t
a
l
.
[
1
9
]
5
1
M
P
T
2
1
0
D
C
I
S
W
i
t
h
i
n
,
I
p
s
i
l
a
t
e
r
a
l
M
e
t
a
s
t
a
t
i
c
c
a
r
c
i
n
o
m
a
i
n
2
o
f
1
2
l
y
m
p
h
n
o
d
e
s
A
W
a
t
1
1
m
o
n
t
h
s
K
e
f
e
l
i
e
t
a
l
.
[
2
0
]
2
6
M
P
T
4
5
I
D
C
I
p
s
i
l
a
t
e
r
a
l
L
i
p
o
s
a
r
c
o
m
a
t
o
u
s
a
n
d
c
h
o
n
d
r
o
s
a
r
c
o
m
a
t
o
u
s
s
t
r
o
m
a
i
n
P
T
;
h
i
s
t
o
r
y
o
f
o
s
t
e
o
s
a
r
c
o
m
a
a
n
d
r
a
d
i
o
t
h
e
r
a
p
y
R
I
P
a
f
t
e
r
1
2
m
o
n
t
h
s
‡4 Pathology Research International
T
a
b
l
e
1
:
C
o
n
t
i
n
u
e
d
.
R
e
p
o
r
t
A
g
e
P
T
t
y
p
e
S
i
z
e
(
m
m
)
A
s
s
o
c
i
a
t
e
d
c
a
r
c
i
n
o
m
a
L
o
c
a
t
i
o
n
o
f
c
a
r
c
i
n
o
m
a
r
e
l
a
t
i
v
e
t
o
P
T
C
o
m
m
e
n
t
O
u
t
c
o
m
e
I
n
v
a
s
i
v
e
I
n
s
i
t
u
S
u
g
i
e
e
t
a
l
.
[
2
1
]
5
4
M
P
T
6
0
I
D
C
D
C
I
S
W
i
t
h
i
n
C
a
r
c
i
n
o
m
a
s
h
o
w
e
d
s
q
u
a
m
o
u
s
d
i
ﬀ
e
r
e
n
t
i
a
t
i
o
n
R
I
P
a
f
t
e
r
4
0
m
o
n
t
h
s
f
r
o
m
m
e
t
a
s
t
a
t
i
c
P
T
M
e
r
c
k
e
t
a
l
.
[
2
2
]
N
S
M
P
T
N
S
I
D
C
C
o
n
t
r
a
l
a
t
e
r
a
l
A
W
a
t
3
2
m
o
n
t
h
s
N
o
m
u
r
a
e
t
a
l
.
[
2
3
]
7
5
M
P
T
3
5
D
C
I
S
W
i
t
h
i
n
A
W
a
t
3
2
m
o
n
t
h
s
L
i
m
a
n
d
T
a
n
[
2
4
]
4
5
M
P
T
1
2
0
D
C
I
S
W
i
t
h
i
n
L
i
p
o
s
a
r
c
o
m
a
t
o
u
s
d
i
ﬀ
e
r
e
n
t
i
a
t
i
o
n
i
n
P
T
;
t
w
o
F
A
s
i
n
c
o
n
t
r
a
l
a
t
e
r
a
l
b
r
e
a
s
t
R
I
P
a
f
t
e
r
1
0
8
m
o
n
t
h
s
f
r
o
m
u
n
r
e
l
a
t
e
d
c
a
u
s
e
T
a
n
e
t
a
l
.
[
1
7
]
N
S
M
P
T
N
S
D
C
I
S
W
i
t
h
i
n
A
u
e
r
b
a
c
h
[
2
5
]
6
9
M
P
T
N
S
I
D
C
I
p
s
i
l
a
t
e
r
a
l
P
T
r
e
c
u
r
r
e
d
a
f
t
e
r
4
0
m
o
n
t
h
s
w
i
t
h
m
e
t
a
s
t
a
s
e
s
R
I
P
a
f
t
e
r
5
1
m
o
n
t
h
s
f
r
o
m
m
e
t
a
s
t
a
s
e
s
†
G
e
b
r
i
m
e
t
a
l
.
[
2
6
]
5
8
M
P
T
3
0
0
I
L
C
C
o
n
t
r
a
l
a
t
e
r
a
l
I
L
C
w
i
t
h
i
n
F
A
i
n
c
o
n
t
r
a
l
a
t
e
r
a
l
b
r
e
a
s
t
A
W
a
t
8
4
m
o
n
t
h
s
N
i
s
h
i
m
u
r
a
e
t
a
l
.
[
2
7
]
8
0
M
P
T
1
0
5
D
C
I
S
W
i
t
h
i
n
O
s
t
e
o
s
a
r
c
o
m
a
t
o
u
s
,
r
h
a
b
d
o
m
y
o
s
a
r
c
o
m
a
t
o
u
s
,
ﬁ
b
r
o
s
a
r
c
o
m
a
t
o
u
s
s
t
r
o
m
a
i
n
P
T
R
I
P
a
f
t
e
r
3
m
o
n
t
h
s
f
r
o
m
m
e
t
a
s
t
a
s
e
s
†
P
a
d
m
a
n
a
b
h
a
n
e
t
a
l
.
[
2
8
]
4
7
M
P
T
7
5
L
C
I
S
W
i
t
h
i
n
L
i
p
o
s
a
r
c
o
m
a
t
o
u
s
a
n
d
ﬁ
b
r
o
s
a
r
c
o
m
a
t
o
u
s
s
t
r
o
m
a
i
n
P
T
A
W
a
t
6
m
o
n
t
h
s
K
a
s
a
m
i
e
t
a
l
.
[
2
9
]
4
7
M
P
T
N
S
I
L
C
C
o
n
t
r
a
l
a
t
e
r
a
l
4
6
X
X
/
4
6
X
Y
m
o
s
a
i
c
k
a
r
y
o
t
y
p
e
;
t
h
r
e
e
s
i
s
t
e
r
s
w
i
t
h
b
r
e
a
s
t
c
a
r
c
i
n
o
m
a
.
R
e
c
u
r
r
e
n
t
P
T
a
t
a
u
t
o
p
s
y
N
A
P
o
w
e
l
l
a
n
d
R
o
s
e
n
[
3
0
]
1
7
–
7
1
M
P
T
8
–
1
0
0
D
C
I
S
I
p
s
i
l
a
t
e
r
a
l
L
i
p
o
s
a
r
c
o
m
a
t
o
u
s
s
t
r
o
m
a
i
n
P
T
N
A
P
o
w
e
l
l
a
n
d
R
o
s
e
n
[
3
0
]
1
7
–
7
1
M
P
T
8
–
1
0
0
L
C
I
S
C
o
n
t
r
a
l
a
t
e
r
a
l
L
i
p
o
s
a
r
c
o
m
a
t
o
u
s
s
t
r
o
m
a
i
n
P
T
N
A
P
o
w
e
l
l
a
n
d
R
o
s
e
n
[
3
0
]
1
7
–
7
1
M
P
T
8
–
1
0
0
I
D
C
D
C
I
S
I
p
s
i
l
a
t
e
r
a
l
,
C
o
n
t
r
a
l
a
t
e
r
a
l
I
n
i
t
i
a
l
l
y
B
P
T
,
r
e
c
u
r
r
e
d
a
s
M
P
T
w
i
t
h
l
i
p
o
s
a
r
c
o
m
a
t
o
u
s
d
i
ﬀ
e
r
e
n
t
i
a
t
i
o
n
i
n
P
T
;
I
p
s
i
l
a
t
e
r
a
l
D
C
I
S
;
C
o
n
t
r
a
l
a
t
e
r
a
l
I
D
C
N
A
M
o
r
i
m
o
t
o
e
t
a
l
.
[
3
1
]
4
9
M
P
T
1
1
0
L
C
I
S
C
o
n
t
r
a
l
a
t
e
r
a
l
L
C
I
S
w
i
t
h
i
n
c
o
n
t
r
a
l
a
t
e
r
a
l
F
A
A
W
a
t
1
3
2
m
o
n
t
h
s
C
h
r
i
s
t
e
n
s
e
n
e
t
a
l
.
[
1
1
]
4
2
–
5
8
M
P
T
L
C
I
S
I
p
s
i
l
a
t
e
r
a
l
R
I
P
a
f
t
e
r
1
2
m
o
n
t
h
s
f
r
o
m
m
e
t
a
s
t
a
t
i
c
P
T
H
u
n
t
r
a
k
o
o
n
[
3
2
]
3
1
M
P
T
9
0
I
D
C
D
C
I
S
I
p
s
i
l
a
t
e
r
a
l
A
W
a
t
2
4
m
o
n
t
h
s
S
e
e
m
a
y
e
r
e
t
a
l
.
[
3
3
]
2
7
S
t
r
o
m
a
l
s
a
r
c
o
m
a
∗
∗
∗
6
0
D
C
I
S
W
i
t
h
i
n
L
i
p
o
s
a
r
c
o
m
a
t
o
u
s
d
i
ﬀ
e
r
e
n
t
i
a
t
i
o
n
i
n
P
T
.
C
o
n
t
r
a
l
a
t
e
r
a
l
M
P
T
a
f
t
e
r
i
n
i
t
i
a
l
m
a
s
t
e
c
t
o
m
y
N
A
C
u
r
r
e
n
t
c
a
s
e
4
3
M
P
T
3
5
I
D
C
D
C
I
S
,
L
C
I
S
W
i
t
h
i
n
,
I
p
s
i
l
a
t
e
r
a
l
L
i
p
o
s
a
r
c
o
m
a
t
o
u
s
d
i
ﬀ
e
r
e
n
t
i
a
t
i
o
n
i
n
P
T
.
D
C
I
S
w
i
t
h
i
n
P
T
.
I
D
C
a
n
d
L
C
I
S
i
n
i
p
s
i
l
a
t
e
r
a
l
b
r
e
a
s
t
.
P
r
e
v
i
o
u
s
r
a
d
i
o
t
h
e
r
a
p
y
f
o
r
l
y
m
p
h
o
m
a
.
A
W
a
t
1
2
m
o
n
t
h
s
∗
C
a
t
e
g
o
r
y
o
f
P
T
n
o
t
s
p
e
c
i
ﬁ
e
d
i
n
o
r
i
g
i
n
a
l
r
e
p
o
r
t
,
i
n
t
e
r
p
r
e
t
e
d
a
s
b
e
n
i
g
n
P
T
.
∗
∗
C
l
a
s
s
i
ﬁ
e
d
a
s
s
c
i
r
r
h
o
u
s
a
d
e
n
o
c
a
r
c
i
n
o
m
a
.
∗
∗
∗
S
a
r
c
o
m
a
t
o
u
s
s
t
r
o
m
a
w
i
t
h
l
i
p
o
s
a
r
c
o
m
a
t
o
u
s
d
i
ﬀ
e
r
e
n
t
i
a
t
i
o
n
,
t
u
m
o
u
r
l
a
c
k
e
d
c
i
r
c
u
m
s
c
r
i
p
t
i
o
n
a
n
d
f
e
a
t
u
r
e
s
o
f
P
T
,
f
o
r
e
x
a
m
p
l
e
,
l
e
a
f
-
l
i
k
e
s
t
r
u
c
t
u
r
e
s
w
e
r
e
n
o
t
p
r
e
s
e
n
t
.
†
M
e
t
a
s
t
a
t
i
c
c
o
m
p
o
n
e
n
t
(
s
a
r
c
o
m
a
v
e
r
s
u
s
c
a
r
c
i
n
o
m
a
)
n
o
t
s
p
e
c
i
ﬁ
e
d
.
‡
C
a
u
s
e
n
o
t
s
p
e
c
i
ﬁ
e
d
.
∞
C
a
t
e
g
o
r
y
o
f
P
T
n
o
t
s
p
e
c
i
ﬁ
e
d
.
A
W
:
a
l
i
v
e
a
n
d
w
e
l
l
:
B
P
T
,
b
e
n
i
g
n
P
T
:
B
L
P
T
,
b
o
r
d
e
r
l
i
n
e
P
T
:
D
C
I
S
,
d
u
c
t
a
l
c
a
r
c
i
n
o
m
a
i
n
s
i
t
u
:
F
A
,
ﬁ
b
r
o
a
d
e
n
o
m
a
:
I
D
C
,
i
n
v
a
s
i
v
e
d
u
c
t
a
l
c
a
r
c
i
n
o
m
a
:
I
L
C
,
i
n
v
a
s
i
v
e
l
o
b
u
l
a
r
c
a
r
c
i
n
o
m
a
:
I
T
C
,
i
n
v
a
s
i
v
e
t
u
b
u
l
a
r
c
a
r
c
i
n
o
m
a
:
L
C
I
S
,
l
o
b
u
l
a
r
c
a
r
c
i
n
o
m
a
i
n
s
i
t
u
:
L
N
,
l
y
m
p
h
n
o
d
e
:
M
P
T
,
m
a
l
i
g
n
a
n
t
P
T
:
N
A
,
n
o
t
a
v
a
i
l
a
b
l
e
:
N
S
,
n
o
t
s
p
e
c
i
ﬁ
e
d
.Pathology Research International 5
(a) (b)
(c) (d)
Figure 2: Pathological features within phyllodes tumour: (a) leaf-like architecture of the phyllodes tumour (H&E, original magniﬁcation
40x); (b) ﬁbrosarcomatous stroma (H&E, original magniﬁcation 100x); (c) liposarcomatous diﬀerentiation in the stroma. Note the presence
of lipoblasts (H&E, original magniﬁcation 200x); (d) DCIS, intermediate nuclear grade (H&E, original magniﬁcation 400x).
that can be seen in association with a PT, including both
liposarcomatous stroma and DCIS within the tumour and
DCIS, LCIS, and invasive carcinoma in the peritumoural
ipsilateral breast.
Malignant epithelial elements are reported in all cate-
gories of PT. In situ and invasive carcinoma may involve
the tumour itself and/or coexist with a PT elsewhere in the
same or contralateral breast. Carcinoma is most commonly
reported (n = 19) in malignant PTs. In the malignant
PT category, carcinoma occurred more frequently in the
ipsilateral [11, 20, 25, 30, 32] or contralateral [22, 26, 29–31]
breast rather than within the conﬁnes of the PT (n = 7) [17,
21, 23, 24, 27, 28, 33]. Coexisting carcinoma in malignant
PTs is more commonly ductal (invasive ductal carcinoma, n
= 6; DCIS, n = 10) than lobular phenotype (invasive lobular
carcinoma, n = 2; LCIS, n = 4) [11, 17, 19–33]. Heterologous
stroma, most often liposarcomatous diﬀerentiation, was
common in malignant PTs where carcinoma was also found
(n = 8, 47%) [20, 21, 24, 27, 30, 33]. From the available data,
ﬁve patients with malignant PTs with coexisting carcinoma
diedfrommetastaticPT,betweenthreemonthsto51months
after diagnosis [11, 20, 21, 25, 27], and one patient had
metastatic carcinoma in two lymph nodes [19].
Carcinoma is less common in benign PTs compared with
malignant PTs, given the higher prevalence of the former.
Coexistentcarcinomaisreportedin16benignPTs(including
four of unspeciﬁed malignant potential) [7, 13, 17]a n d
in three of these cases it was only seen in a recurrence
of a benign PT [11, 13, 14]. Carcinoma was found more
commonly within the benign PT (n = 10) [1, 4–6, 8–10, 12,
14,17]ratherthanperipheraltoitintheipsilateral(n=5)[7,
11, 15–17] or contralateral breast (n = 1) [13]. The majority
of these carcinomas (n = 10) were invasive, with or without
an in situ component and most were ductal NST type (n =
6) [1, 7, 8, 11, 13, 15] with individual reports of invasive
lobular [6], papillotubular [12], and tubular carcinoma
[14]. One case had both invasive squamous carcinoma and
invasive ductal carcinoma showing clear cell, secretory, and
squamous diﬀerentiation [5]. Two patients died from breast
disease [11, 15], one of which had metastatic carcinoma in
lymphnodes[15].Anotherpatienthadmetastaticcarcinoma
infourlymphnodesbutremainedaliveandwellatfollow-up
[1].
There are only three reports of carcinoma (DCIS) arising
in association with borderline PT. Two patients had DCIS
both within the PT and in the ipsilateral breast [11, 18], one6 Pathology Research International
(a) (b)
(c) (d)
Figure 3: Pathological features in ipsilateral breast peripheral to phyllodes tumour(a)Invasive tubular carcinoma (H&E, original
magniﬁcation 200x); (b) LCIS (H&E, original magniﬁcation 200x); (c) LCIS showing downregulation in E-Cadherin staining (E-Cadherin,
original magniﬁcation 200x); (d) DCIS, high nuclear grade with comedonecrosis and calciﬁcation (H&E, original magniﬁcation 200x).
of whom died within three years from unrelated causes. In
the other case, DCIS occurred in the ipsilateral breast at the
time of diagnosis of a recurrent PT and death occurred from
metastatic PT one year after the recurrence [18].
The molecular events involved in transformation and
progression of PTs are largely unknown, and the rarity
of coexisting epithelial malignancy makes it diﬃcult to
draw conclusions about the aetiological association between
the carcinoma and PT in these cases. Genetic aberrations
have been consistently demonstrated in PTs with increasing
frequency from benign to borderline to malignant PTs. Most
studies to date focused on stromal alterations and showed
r e c u r r e n tc o p yn u m b e rg a i n sa n dl o s s e sa t+ 1 q ,−13q, −6q,
+5, and −10p [37–39]. Where epithelium was evaluated sep-
arately, distinct molecular alterations were demonstrated in
the Wnt2-APC-B-catenin pathway, and a role was postulated
forbothstromaandepitheliumintheneoplasticprocess[40,
41]. It is unclear, however, if the malignant transformation
of epithelium results from stromal-epithelial interactions
within the PT or if it represents cancerisation of a PT by
carcinoma arising in the duct system peripheral to the PT.
Thelattermay playa rolein caseswherecarcinomais present
within the PT as well as peripheral to it in the ipsilateral
breast. The ﬁnding of carcinoma in benign, borderline, and
malignant PT and within ﬁbroadenomas suggests that it
is unlikely to be directly related to the number of genetic
aberrations in the diﬀerent categories of PT. A role of
exogenouscarcinogenexposureinmalignanttransformation
merits consideration as an aetiological agent because two
patients [10, 20] in addition to the present case had a history
of previous radiation. In all cases the radiotherapy ﬁeld was
remote from the breast which suggest that it is likely to be
incidental.
The present case taken together with those in the litera-
ture demonstrates the diverse pathology that can be found
with PTs, both within the tumour and in the surround-
ing and/or contralateral breast. The distinction between a
malignant PT with coexisting carcinoma and a metaplastic
carcinoma or carcinosarcoma should be considered in the
diagnosis as these entities are managed diﬀerently and the
distinction aﬀects patient outcome. Carcinosarcomas have
mixed malignant epithelial and stromal components with
the latter showing no reactivity for epithelial immunohisto-
chemicalmarkers.Whilethepresentcasefulﬁlsthesecriteria,
the characteristic leaf-like structure with malignant heterol-
ogous diﬀerentiation favours a diagnosis of malignant PTPathology Research International 7
withcoexistingcarcinomaratherthanatruecarcinosarcoma.
Carcinomas coexisting with PTs are generally diagnosed
incidentally on the wide local excision, and the prognosis
is dictated by the category of PT. In the present case, the
malignant PT and not the carcinomatous elements will have
the greatest impact on prognosis. However, the presence
of coexistent carcinoma must be taken into account in
management decisions, especially for benign and borderline
PTs.Wider adequacyof excision of carcinoma, as in this case,
and lymph node sampling should be considered.
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